PubMed=15160996
Akiyama Y., Maruyama K., Nara N., Mochizuki T., Yamamoto A., Yamazaki N., Kawashima I., Nukaya I., Takesako K., Yamaguchi K.
Cytotoxic T cell induction against human malignant melanoma cells using HLA-A24-restricted melanoma peptide cocktail.
Anticancer Res. 24:571-577(2004)

PubMed=15467732; DOI=10.1038/sj.onc.1208152
Tanami H., Imoto I., Hirasawa A., Yuki Y., Sonoda I., Inoue J., Yasui K., Misawa-Furihata A., Kawakami Y., Inazawa J.
Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.
Oncogene 23:8796-8804(2004)

PubMed=19035443; DOI=10.1002/ijc.24048
Ashida A., Takata M., Murata H., Kido K., Saida T.
Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.
Int. J. Cancer 124:862-868(2009)

PubMed=22578220; DOI=10.1111/j.1755-148X.2012.01016.x
Furney S.J., Turajlic S., Fenwick K., Lambros M.B., Mackay A., Ricken G., Mitsopoulos C., Kozarewa I., Hakas J., Zvelebil M., Lord C.J., Ashworth A., Reis-Filho J.S., Herlyn M., Murata H., Marais R.
Genomic characterisation of acral melanoma cell lines.
Pigment Cell Melanoma Res. 25:488-492(2012)